Dart NeuroScience LLC develops technologies and therapeutics to maximize cognitive vitality throughout life. Its research program includes developing methods of gene discovery, gene network informatics, drug discovery, and chemistry to identify small molecules for use as therapies for various brain disorders. DNS currently has three drugs in clinical studies and drug programs for 10 additional innovative targets in earlier stages of discovery. The company was founded in 2008 and is based in San Diego, California.